Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Frontiers in Immunology
|
June 3, 2025
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19
Britta Westhus, Patrick Thon, Lars Palmowski, et al.
Frontiers in Immunology
|
November 20, 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patients
Birte Dyck, Ulrich Bosch Dos Santos, Corinna Müller, et al.
International Journal of Molecular Sciences
|
February 10, 2024
The Aquaporin 3 Polymorphism (rs17553719) Is Associated with Sepsis Survival and Correlated with IL-33 Secretion
Dominik Ziehe, Britta Marko, Patrick Thon, et al.
Critical Care (London, England)
|
September 2, 2025
Plasma proteomics identifies molecular subtypes in sepsis
Thilo Bracht, Kerstin Kappler, Malte Bayer, et al.
International Journal of Molecular Sciences
|
January 27, 2024
AQP3 and AQP9-Contrary Players in Sepsis?
Patrick Thon, Tim Rahmel, Dominik Ziehe, et al.
Frontiers in Immunology
|
May 23, 2024
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis
Dominik Ziehe, Alexander Wolf, Tim Rahmel, et al.
Pathogens (Basel, Switzerland)
|
February 27, 2026
Human Cytomegalovirus Serostatus Defines Cytokine-Based Predictive Signatures in Sepsis
Frederik Krause, Birte Dyck, Kerstin Kappler, et al.
Intensive Care Medicine
|
June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial
Thorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
BMJ Open
|
September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)
Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
Critical Care (London, England)
|
May 30, 2026
Phosphorylated toll-like receptor 4 defines a high-risk sepsis endotype
Madita Mühlhaus, Birte Dyck, Andrea Witowski, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Frontiers in Immunology
|
June 3, 2025
The protein interaction of mitochondrial transcription factors A and B2 is associated with 30-day survival in critical COVID-19
Britta Westhus, Patrick Thon, Lars Palmowski, et al.
Frontiers in Immunology
|
November 20, 2025
AIMing for survival: The impact of the free and total AIM concentration in septic patients
Birte Dyck, Ulrich Bosch Dos Santos, Corinna Müller, et al.
International Journal of Molecular Sciences
|
February 10, 2024
The Aquaporin 3 Polymorphism (rs17553719) Is Associated with Sepsis Survival and Correlated with IL-33 Secretion
Dominik Ziehe, Britta Marko, Patrick Thon, et al.
Critical Care (London, England)
|
September 2, 2025
Plasma proteomics identifies molecular subtypes in sepsis
Thilo Bracht, Kerstin Kappler, Malte Bayer, et al.
International Journal of Molecular Sciences
|
January 27, 2024
AQP3 and AQP9-Contrary Players in Sepsis?
Patrick Thon, Tim Rahmel, Dominik Ziehe, et al.
Frontiers in Immunology
|
May 23, 2024
Exploring the relationship between HCMV serostatus and outcomes in COVID-19 sepsis
Dominik Ziehe, Alexander Wolf, Tim Rahmel, et al.
Pathogens (Basel, Switzerland)
|
February 27, 2026
Human Cytomegalovirus Serostatus Defines Cytokine-Based Predictive Signatures in Sepsis
Frederik Krause, Birte Dyck, Kerstin Kappler, et al.
Intensive Care Medicine
|
June 30, 2026
Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial
Thorsten Brenner, Annabell Skarabis, Stefan J Schaller, et al.
BMJ Open
|
September 22, 2025
Randomised controlled study investigating standard dose continuous renal replacement therapy (CRRT) versus low-dose CRRT in critically ill patients with acute kidney injury (AKI): study protocol for a prospective, randomised, controlled, international, multicentre trial (the 'Ketzerei' trial)
Christian Strauß, Mahan Sadjadi, Thilo von Groote, et al.
Critical Care (London, England)
|
May 30, 2026
Phosphorylated toll-like receptor 4 defines a high-risk sepsis endotype
Madita Mühlhaus, Birte Dyck, Andrea Witowski, et al.
Page
of 5